Research

FATTY ACID COULD KILL HUMAN CANCER CELLS

Researchers have demonstrated that a fatty acid called dihomogamma-linolenic acid, or DGLA, can kill human cancer cells. The study, published in Developmental Cell on July 10, found that DGLA can induce ferroptosis in an animal model and in actual human cancer cells. Ferroptosis is an iron-dependent type of cell death that was discovered in recent years and has become a focal point for disease research as it is closely related to many disease processes. Jennifer Watts, a Washington State University…

Research

RESEARCHERS AT JOHN HOPKINS UNIVERSITY USE NANOPARTICLES TO TREAT MACULAR DEGENERATION

Wet age-related macular degeneration and a number of other eye diseases, including congenital conditions, are related to mutated genes that result in blood vessel abnormalities. These can be treated with gene therapy, but delivering genetic material has proven to be difficult when dealing with large gene sequences that are common in retinal conditions. Viruses have been the go-to vectors for delivering genes into the eye, but the immune system wants to fight them. Too often this results in poor efficacy…

Features

FIRST TECHNOLOGICAL SOLUTION FOR ADVANCED HEALTH MONITORING OF STROKE SURVIVORS

Group of biomedical engineers from biotech company Gruppo Fos Lithuania together with researchers at Kaunas University of Technology and Lithuanian University of Health Sciences have patented technology for advanced health monitoring of stroke survivors. It is the first solution in the world which monitors and analyses simultaneously a patient’s health parameters from the affected part of the brain and those of the cardiovascular system. Stroke is a sudden impairment of the cerebral circulation, resulting in the death of the brain…

Features

Energy efficient robotic prosthetic legs for a natural walk

Researchers at the University of Michigan have developed robotic prosthetic legs which use motors that were originally designed for use on the robotic arm of the International Space Station. The motors allow the prostheses to move more naturally, producing less stress on the hips of users, and they are also quieter and more energy efficient than pre-existing robotic legs. Conventional prosthetic legs require the wearer to move their hips abnormally to raise the foot and swing the leg forward. This…

Features

World’s First Phase III covid-19 clinical trial inactivated Vaccine begins in the UAE

The trials are being operated by health practitioners from SEHA who are providing facilities at five of their sites in Abu Dhabi and Al Ain in addition to a mobile clinic to ensure the trials are readily accessible to volunteers participating in the program The first WHO enlisted global clinical Phase III trial of Sinopharm CNBG’s inactivated vaccine to combat COVID-19 has started in Abu Dhabi and has been inspired by the UAE Leadership’s vision and commitment to overcome the…